Healthcare manufacturing facility incorporating major clean room areas and testing facilities. The first phase was won by competitive tender. Phases 2 and 3 were negotiated and undertaken on a fast track basis.

This was Boston Scientific’s first manufacturing and research and development facility researching the use of drug-eluting stents to treat blockages of coronary arteries.

The total area of the project was 32,430 sq.m.

• Phase 1 5,500 including 1,600m.sq. Class 10,000 Clean room
• Phase 2 11,00 including 8,000m.sq. Class 10,000 Clean room
• Phase 3 15,000 including 11,000m.sq. Class 10,000 Clean room